News for Coherus BioSciences, Inc. (CHRS)

Coherus BioSciences Inc (CHRS) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue is $47.27 million, and the e

**media[555576]**

REDWOOD CITY, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (”œCoherus,” CHRS) today announced that senior management will participa

**media[548703]**

**media[517340,517341]**

PR NewswirePLYMOUTH MEETING, Pa., Jan. 9, 2025 PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on

Coherus BioSciences is expanding in immunotherapy while managing financial risks. Learn why CHRS stock may benefit from the company's strategic decisions.

Coherus price target raised at Baird on agreement to sell Udenyca

North Carolina-based Cheetah Net Supply Chain Service Inc. (CTNT) is up over 267 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Coherus BioSciences divests UDENYCA franchise to Intas Pharmaceuticals for up to $558.4 million, strengthening financial position and focusing on...

**media[481935]**

- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (”œCoherus,” CHRS) today announced that senior management will participa

**media[477959]**

**media[459115]**

Neutropenia treatment industry is projected to witness a CAGR of 4.1% during the period 2024-2032. This growth can be attributed to rising R&D efforts...

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

UBS cuts Coherus shares target amid concerns over future revenue growth

Texas-based Iteris, Inc., a provider of intelligent transportation systems technology solutions is up over 62 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.